Fisher, NJ
David John Fisher, Berlin, NJ US
Patent application number | Description | Published |
---|---|---|
20100115714 | Retractable ramp system - A retractable ramp system mounts a slideable ramp between lateral rail members which extend the length of a truck chassis and a container mounted thereon. The ramp is slideably suspended from a guide rail running parallel to the lateral rail members by means of a carriage component, itself slideably mounted within the guide rail. It is readily and easily extended and retracted by one person. When positioned directly on a truck chassis, the rail system is located above the hydraulic, electrical, and other mechanical systems positioned within the well of the truck chassis, such that the ramp is slideably moveable over these system components without interfering with them or any other part of the truck chassis. The ramp system is conveniently used for loading and off-loading containers which rest on the truck chassis or which are elevated above the chassis. | 05-13-2010 |
Dwayne Fisher, Kendall Park, NJ US
Patent application number | Description | Published |
---|---|---|
20100010930 | PROVIDING A REAL TIME CREDIT SCORE AS PART OF A TRANSACTION REQUEST - Providing a real time credit score to a transaction account issuer as part of the transaction authorization request message is disclosed. A payment processor augments the transaction request received from a customer or merchant by calculating a credit score and adding it to the authorization request message. The real time credit score calculation may be based upon data stored by the payment processor and upon information collected from credit bureaus, transaction account issuers and other third-party sources. | 01-14-2010 |
Francis Joseph Fisher, Southampton, NJ US
Patent application number | Description | Published |
---|---|---|
20100115714 | Retractable ramp system - A retractable ramp system mounts a slideable ramp between lateral rail members which extend the length of a truck chassis and a container mounted thereon. The ramp is slideably suspended from a guide rail running parallel to the lateral rail members by means of a carriage component, itself slideably mounted within the guide rail. It is readily and easily extended and retracted by one person. When positioned directly on a truck chassis, the rail system is located above the hydraulic, electrical, and other mechanical systems positioned within the well of the truck chassis, such that the ramp is slideably moveable over these system components without interfering with them or any other part of the truck chassis. The ramp system is conveniently used for loading and off-loading containers which rest on the truck chassis or which are elevated above the chassis. | 05-13-2010 |
Frank Fisher, Hoboken, NJ US
Patent application number | Description | Published |
---|---|---|
20150333598 | VIBRATIONAL ENERGY HARVESTING FOR STRUCTURAL HEALTH INSTRUMENTATION - A system includes a vibrational energy harvesting device adapted to receive vibrational energy and convert the vibrational energy to electrical energy. The system also includes a computing device having an electrical connection to the vibrational energy harvesting device. The system also includes a sensor having an electrical connection and a data connection to the computing device. The system also includes a transmitter having an electrical connection and a data connection to the computing device. When the computing device receives the electrical energy from the vibrational energy harvesting device, the computing device is configured to receive sensor data from the sensor via the data connection between the computing device and the sensor and operate the transmitter to wirelessly transmit the sensor data. | 11-19-2015 |
Frank Fisher, Union City, NJ US
Patent application number | Description | Published |
---|---|---|
20140127584 | POPCORN-LIKE GROWTH OF GRAPHENE-CARBON NANOTUBE MULTI-STACK HYBRID THREE-DIMENSIONAL ARCHITECTURE FOR ENERGY STORAGE DEVICES - Graphene-carbon nanotube multi-stack three-dimensional architectures (graphene-CNT stacks) are formed by a “popcorn-like” growth method, in which carbon nanotubes are grown throughout the architecture in a continuous step. Alternating layers of graphene and a transition metal are grown by a vapor deposition process. The metal is fragmented and etched to form an array of catalytic sites. Carbon nanotubes grow from the catalytic sites in a vapor-solid-liquid process. The graphene-CNT stacks have applications in electrical energy storage devices, such as supercapacitors and batteries. The directly grown carbon nanotube array between graphene layers provides ease of ion diffusion and electron transfer, in addition to being an active material, spacer and electron pathway. | 05-08-2014 |
Harold Fisher, Piscataway, NJ US
Patent application number | Description | Published |
---|---|---|
20120045306 | UTILITY WAGON AND AN ATTACHABLE LEAF CHUTE - A wagon comprising a body portion, the body portion including a plurality of side portions, each of the side portions comprising wire or plastic sides. The wagon also comprises a plurality of reinforcing metal strips on a top and bottom of each of the wire sides; and a plurality of metal strips which extend from the top to the bottom of the body portion. Finally, the wagon includes a plurality of tie down straps in metal or plastic straps extending from a top portion of and side of the utility wagon. When an attachable leaf chute is combined with the utility wagon, it can also fill individual bags with leaves. The attachable leaf chute slides into and then is attached to the utility wagon. | 02-23-2012 |
Jody Fisher, Voorhees, NJ US
Patent application number | Description | Published |
---|---|---|
20100114607 | METHOD AND SYSTEM FOR PROVIDING REPORTS AND SEGMENTATION OF PHYSICIAN ACTIVITIES - A system includes a database with at least one dataset with at least one data field corresponding to at least one field of data of a medical claim form, a computing platform in communication with the database, and a memory module. The at least one dataset is formed from de-identified provider information. The memory module contains at least one conversion table for converting between a provider identification code and a corresponding provider name. The computing platform receives a request for information, extracts from the database one or more datasets having information responsive to the request, and forms an output table based on the extracted one or more datasets. The table includes the provider name. | 05-06-2010 |
Joseph A. Fisher, Lake Hopatcong, NJ US
Patent application number | Description | Published |
---|---|---|
20110142032 | REUSABLE AND EXTENSIBLE FRAMEWORK FOR MULTIMEDIA APPLICATION DEVELOPMENT - Systems and methods of developing and/or implementing multimedia applications. The system provides an extensible framework including an application layer, a framework utility layer, and a core engine layer. The framework utility layer includes an application programming interface, a video codec sub-framework (XCF), a video packetization sub-framework (XPF), and a video/text overlay sub-framework (XOF). The core engine layer includes one or more core codec engines and one or more core rendering engines. The XCF, XPF, and XOF sub-frameworks are effectively decoupled from the multimedia applications executing on the application layer, and the core codec and rendering engines of the core engine layer, allowing the XCF, XPF, and XOF sub-frameworks and core codec/rendering engines to be independently extensible. The system also fosters enhanced reuse of existing multimedia applications across a plurality of multimedia systems. | 06-16-2011 |
20110142121 | REUSABLE AND EXTENSIBLE FRAMEWORK FOR MULTIMEDIA APPLICATION DEVELOPMENT - Systems and methods of developing and/or implementing multimedia applications. The system provides an extensible framework including an application layer, a framework utility layer, and a core engine layer. The framework utility layer includes an application programming interface, a video codec sub-framework (XCF), a video packetization sub-framework (XPF), and a video/text overlay sub-framework (XOF). The core engine layer includes one or more core codec engines and one or more core rendering engines. The XCF, XPF, and XOF sub-frameworks are effectively decoupled from the multimedia applications executing on the application layer, and the core codec and rendering engines of the core engine layer, allowing the XCF, XPF, and XOF sub-frameworks and core codec/rendering engines to be independently extensible. The system also fosters enhanced reuse of existing multimedia applications across a plurality of multimedia systems. | 06-16-2011 |
Michael H. Fisher, Ringoes, NJ US
Patent application number | Description | Published |
---|---|---|
20090074890 | Substituted Triazoles as Sodium Channel Blockers - Substituted triazole compounds represented by Formula I, II or III, or pharmaceutically acceptable salts thereof. Pharmaceutical compositions comprise an effective amount of the instant compounds, either alone, or in combination with one or more other therapeutically active compounds, and a pharmaceutically acceptable carrier. Methods of treating conditions associated with, or caused by, sodium channel activity, including, for example, acute pain, chronic pain, visceral pain, inflammatory pain, neuropathic pain, migraine, headache pain, migraine headache, epilepsy, irritable bowel syndrome, diabetic neuropathy, multiple sclerosis, manic depression and bipolar disorder, comprise administering an effective amount of the present compounds, either alone, or in combination with one or more other therapeutically active compounds. A method of administering local anesthesia comprises administering an effective amount of a compound of the instant invention, either alone, or in combination with one or more other therapeutically active compounds, and a pharmaceutically acceptable carrier (I), (II), (III). | 03-19-2009 |
20100130504 | BETA-AMINO HETEROCYCLIC DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES - The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. | 05-27-2010 |
20110190308 | NOVEL CYCLIC AZABENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS - The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. | 08-04-2011 |
Michael H. Fisher, Flemington, NJ US
Patent application number | Description | Published |
---|---|---|
20130217695 | BETA-AMINO HETEROCYCLIC DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES - The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. | 08-22-2013 |
Steven Fisher, Middlesex, NJ US
Patent application number | Description | Published |
---|---|---|
20140086851 | Low Water Metal Ion Dentifrice - A dentifrice composition having a low water phase comprising effective amounts of polyphosphate and ionic active ingredients. The composition comprises a source of metal ions, an inorganic phosphate salt having four or more phosphorus atoms and a cross-linked polyvinylpyrrolidone thickening agent in a single phase. Preferred metal ions are stannous, copper and zinc, in particular from zinc citrate and stannous fluoride. | 03-27-2014 |
20140314690 | ORAL CARE COMPOSITIONS - Described herein are preservative systems which prevent the growth of microorganisms in silica based dentifrices, compositions comprising the same; and methods of making and using the same. | 10-23-2014 |
Steven Fisher, Middlessex, NJ US
Patent application number | Description | Published |
---|---|---|
20120020897 | DENTIFRICE COMPOSITION - The invention encompasses a dentifrice composition comprising an orally acceptable vehicle; a source of zinc ions; and a polysaccharide thickening agent, the polysaccharide thickening agent having at most 0.5 charged groups per sugar residue unit along the polysaccharide backbone such as xanthan gum and/or hydroxyethyl cellulose. | 01-26-2012 |
Steven W. Fisher, Middlesex, NJ US
Patent application number | Description | Published |
---|---|---|
20120042893 | ORAL CARE FORMULATIONS THAT ENHANCE AMOUNT OF SOLUBLE ZINC - An oral care composition and method are described in which the composition includes a film or a plurality of film fragments entrained in a carrier. The film or plurality of film fragments comprises a zinc compound and the carrier comprises a polysaccharide and a maleic anhydride copolymer. The composition and methods provide benefits including one or more of increased consumer acceptability, improved solubility of zinc thus permitting the use of lower amounts of zinc compounds and reducing the adverse astringency associated with zinc, decreased adverse reactions brought about by the presence of zinc ions, enhanced aesthetics, improved stability for active or other functional materials, and controlled delivery of active materials such as zinc. | 02-23-2012 |
20130216485 | Dentifrice Composition with Reduced Astringency - A dentifrice composition containing, in combination, an orally acceptable vehicle; a halogenated diphenyl ether; a soluble zinc salt; and a chelating agent to reduce astringency. | 08-22-2013 |
20150023890 | High Fluoride Ion Oral Care Composition and Method for Maintaining Anticaries Activity - An oral care composition and method of maintaining anticaries activity of fluoride ion in an oral care composition are described. An oral care composition comprises a fluoride ion source sufficient to maintain a high fluoride content in the composition, an effective amount of a desensitizing agent and water. A method of maintaining anti caries activity of fluoride km in an oral care composition comprises providing an oral care composition comprising fluoride ions, an effective amount of a desensitizing agent and water. | 01-22-2015 |
Steven Wade Fisher, Middlesex, NJ US
Patent application number | Description | Published |
---|---|---|
20090087391 | FOAMABLE FLUORIDE ORAL CARE COMPOSITION - A dental fluoride foam composition comprising an aqueous solution of a water soluble fluoride ion releasable salt, a surfactant selected from the group consisting of nonionic surfactants, zwitterionic surfactants, betaine surfactants and mixtures thereof; and an orally compatible acidifying agent in an amount sufficient to adjust the pH of the composition to about 3 to about 5. The composition is stable at low temperatures and is a clear solution substantially free of precipitates when held at 4.4° C. for 12 hours. When dispensed from a container into the trough of a dental tray, the composition forms a low density, rapidly collapsible foam which substantially liquefies in about 1 minute after being dispensed from the foam generating container and placed in contact with a patient's teeth. | 04-02-2009 |
20120207686 | LOW WATER STANNOUS FLUORIDE PLUS ZINC CITRATE DENTIFRICE WITH IMPROVED STABILITY, RHEOLOGY, AND EFFICACY - A dentifrice composition having a low water phase comprising effective amounts of polyphosphate and ionic active ingredients. | 08-16-2012 |
20130287709 | Metal Salt Compositions - Described herein are compositions comprising combinations of metal salts, and methods of preparing and using the same. | 10-31-2013 |
20130330283 | ORAL CARE COMPOSITIONS - Flavour components for use in oral care compositions containing a metal salt, compositions comprising the flavour components, and methods of making and using the same. The flavour components comprise a taste -masking agent comprising cinnamic aldehyde, eugenol and eucalyptol and one or more flavouring agents selected from L-menthol, N-ethyl-p-menthane-3-carboxamide, anethole, peppermint oil, spearmint oil and corn mint oil. In particular the metal salt is zinc citrate. | 12-12-2013 |
Timothy S. Fisher, Plainsboro, NJ US
Patent application number | Description | Published |
---|---|---|
20100040610 | ANTAGONISTS OF PCSK9 - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 02-18-2010 |
20100113575 | METHOD FOR DETECTING AUTOPROCESSED, SECRETED PCSK9 - The present invention provides a method for detecting autoprocessed, secreted PCSK9, a protein involved in cholesterol homeostasis, and for effectively identifying compounds that inhibit autocleavage and secretion from cells. The disclosed method involves the insertion of an epitope tag into a PCSK9 expression construct immediately C-terminal to the pro domain ending at an amino acid residue corresponding to Q152 of human PCSK9. Upon autoprocessing, the epitope tag is exposed and capable of recognition by anti-epitope antibodies or other suitable identification system, allowing for the selective and exclusive identification and/or quantification of processed PCSK9. The present disclosure thus advances the goal of providing enabling technology to the art for the effective identification of therapeutics effective in combating coronary heart disease. | 05-06-2010 |
20120082680 | ANTAGONISTS OF PCSK9 - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 04-05-2012 |